Consistently, we found that aticaprant (a selective and short-acting KOR antagonist) alone decreased alcohol intake and prevented “relapse” drinking in both the excessive alcohol drinking and alcohol relapse-like (ADE) mouse models respectively, with a paralleled reduction of water intake. The gene discussed is OPRK1; the disease is alcohol drinking.